Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
Saved in:
| Title: | Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. |
|---|---|
| Authors: | Sasada S; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Kondo N; Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Hashimoto H; Core Laboratory, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Takahashi Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, 700-8558, Okayama, Japan., Terata K; Department of Breast and Endocrine Surgery, Akita University Hospital, Akita, Japan., Kida K; Department of Breast Surgical Oncology, St. Luke's International Hospital, Tokyo, Japan., Sagara Y; Department of Breast and Thyroid Surgical Oncology, Social medical corporation Hakuaikai, Sagara Hospital, Kagoshima, Japan., Ueno T; Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Anan K; Department of Surgery, Kitakyushu Municipal Medical Center, Kitakyushu, Japan., Suto A; Department of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan., Kanbayashi C; Department of Breast Oncology, Niigata Cancer Center Hospital, Niigata, Japan., Takahashi M; Department of Breast Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan., Nakamura R; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan., Ishiba T; Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Tsuneizumi M; Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Japan., Nishimura S; Department of Breast Surgery, Shizuoka Cancer Center Hospital, Shizuoka, Japan., Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, Chiba, Japan., Hara F; Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, 700-8558, Okayama, Japan. tshien@md.okayama-u.ac.jp., Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Dec; Vol. 202 (3), pp. 473-483. Date of Electronic Publication: 2023 Sep 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-023-07097-6 |
